Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.

Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Longstreth J, Berman N.

J Clin Endocrinol Metab. 2000 Dec;85(12):4500-10.

PMID:
11134099
2.

Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.

Wang C, Berman N, Longstreth JA, Chuapoco B, Hull L, Steiner B, Faulkner S, Dudley RE, Swerdloff RS.

J Clin Endocrinol Metab. 2000 Mar;85(3):964-9.

PMID:
10720024
3.

Comparative pharmacokinetics of three doses of percutaneous dihydrotestosterone gel in healthy elderly men--a clinical research center study.

Wang C, Iranmanesh A, Berman N, McDonald V, Steiner B, Ziel F, Faulkner SM, Dudley RE, Veldhuis JD, Swerdloff RS.

J Clin Endocrinol Metab. 1998 Aug;83(8):2749-57.

PMID:
9709942
4.

Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.

Singh AB, Norris K, Modi N, Sinha-Hikim I, Shen R, Davidson T, Bhasin S.

J Clin Endocrinol Metab. 2001 Jun;86(6):2437-45.

PMID:
11397836
5.

Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.

Meikle AW, Mazer NA, Moellmer JF, Stringham JD, Tolman KG, Sanders SW, Odell WD.

J Clin Endocrinol Metab. 1992 Mar;74(3):623-8.

PMID:
1740497
6.
7.
8.

Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N; Testosterone Gel Study Group..

J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53.

PMID:
10946892
9.

Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate--a clinical research center study.

Salehian B, Wang C, Alexander G, Davidson T, McDonald V, Berman N, Dudley RE, Ziel F, Swerdloff RS.

J Clin Endocrinol Metab. 1995 Dec;80(12):3567-75.

PMID:
8530600
10.

Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.

Jockenhövel F, Vogel E, Kreutzer M, Reinhardt W, Lederbogen S, Reinwein D.

Clin Endocrinol (Oxf). 1996 Jul;45(1):61-71.

PMID:
8796140
11.

Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.

Arver S, Dobs AS, Meikle AW, Caramelli KE, Rajaram L, Sanders SW, Mazer NA.

Clin Endocrinol (Oxf). 1997 Dec;47(6):727-37.

PMID:
9497881
12.

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS.

J Clin Endocrinol Metab. 2004 May;89(5):2085-98.

PMID:
15126525
13.
14.

Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.

Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, Wang C.

J Clin Endocrinol Metab. 2002 Aug;87(8):3562-72.

PMID:
12161475
15.

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.

Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N.

Clin Endocrinol (Oxf). 2001 Jun;54(6):739-50.

PMID:
11422108
16.
17.
18.

Pharmacokinetics of a novel testosterone matrix transdermal system in healthy, premenopausal women and women infected with the human immunodeficiency virus.

Javanbakht M, Singh AB, Mazer NA, Beall G, Sinha-Hikim I, Shen R, Bhasin S.

J Clin Endocrinol Metab. 2000 Jul;85(7):2395-401.

PMID:
10902784
19.

A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.

Zhang GY, Gu YQ, Wang XH, Cui YG, Bremner WJ.

J Androl. 1998 Nov-Dec;19(6):761-8.

Supplemental Content

Support Center